|Podcasts|February 22, 2018
Episode 3: Pharma's Reputation
Author(s)Michelle Maskaly, Christen Harm
In this episode, Christen and Michelle talk to Devyn Smith, chief strategy officer and head of operations for Sigilon Therapeutics, on the topic of pharma's reputation, both in the US and Europe.
Advertisement
In this episode, Christen and Michelle talk to Devyn Smith, chief strategy officer and head of operations for Sigilon Therapeutics, on the topic of pharma's reputation, both in the US and Europe.
You can listen and/or download the episode on SoundCloud or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Origins of Nuvation Bio’s Deal with Daichii Sankyo for the Rights to Safusidenib in Japan
2
Pharma M&A Roundup: AstraZeneca Enters License Deal with Dizal Pharmaceutical, Chai Discovery Enters Collaboration with Novartis, Innovent Biologics Enters License Agreement with Spero Therapeutics
3
FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease
4
Educating Patients About GLP-1s: Q&A with Kristen Hartzell, PharmD
5